THE ASAHI SHIMBUN
February 14, 2021 at 18:50 JST
The COVID-19 vaccine manufactured by U.S. drugmaker Pfizer Inc. (Provided by Pfizer Inc.)
The health ministry on Feb. 14 approved the first use of a vaccine to combat the novel coronavirus.
It is expected to start inoculating health workers with the Pfizer-BionNTech vaccine on Feb. 17.
The vaccine was developed by Pfizer Inc. and its German partner.
Japan has also secured deals for vaccines developed by AstraZeneca Plc, Moderna Inc. and Novavax Inc.
First COVID-19 vaccinations look set to begin from Feb. 17
February 13, 2021
Syringe mix-up to hurt efficiency in COVID-19 vaccine program
February 10, 2021
Production of glass vials for virus vaccine hits rapid pace
February 1, 2021
EDITORIAL: Collaboration with local entities vital for vaccine rollout program
January 30, 2021
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
